    <SEC-DOCUMENT>0001193125-20-139879-index.html : 20200512
    <SEC-HEADER>0001193125-20-139879.hdr.sgml : 20200512
    <ACCEPTANCE-DATETIME>20200512105038
    ACCESSION NUMBER:		0001193125-20-139879
    CONFORMED SUBMISSION TYPE:	8-K
    PUBLIC DOCUMENT COUNT:		4
    CONFORMED PERIOD OF REPORT:	20200512
    ITEM INFORMATION:		Regulation FD Disclosure
    ITEM INFORMATION:		Financial Statements and Exhibits
    FILED AS OF DATE:		20200512
    DATE AS OF CHANGE:		20200512

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Stoke Therapeutics, Inc.
    		CENTRAL INDEX KEY:			0001623526
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		IRS NUMBER:				471144582
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		8-K
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-38938
    		FILM NUMBER:		20867142

    	BUSINESS ADDRESS:
    		STREET 1:		3 PRESTON COURT
    		CITY:			BEDFORD
    		STATE:			MA
    		ZIP:			01730
    		BUSINESS PHONE:		781-430-8200

    	MAIL ADDRESS:
    		STREET 1:		3 PRESTON COURT
    		CITY:			BEDFORD
    		STATE:			MA
    		ZIP:			01730

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	ASOthera Pharmaceuticals, Inc.
    		DATE OF NAME CHANGE:	20141028
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>8-K
    <SEQUENCE>1
    <FILENAME>d876521d8k.htm
    <DESCRIPTION>8-K
    <TEXT>
    Document 1 - file: d876521d8k.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>EX-99.1
    <SEQUENCE>2
    <FILENAME>d876521dex991.htm
    <DESCRIPTION>EX-99.1
    <TEXT>
    Document 2 - file: d876521dex991.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>EX-99.2
    <SEQUENCE>3
    <FILENAME>d876521dex992.htm
    <DESCRIPTION>EX-99.2
    <TEXT>
    Document 3 - file: d876521dex992.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>4
    <FILENAME>g876521ex99p1g1.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 4 - file: g876521ex99p1g1.jpg

    </DOCUMENT>
    </SEC-DOCUMENT>